Error loading player: No playable sources found

5440

Management of Cholestatic Liver Disease

Date
May 21, 2024
This product is not available for individual purchase, but it is available as part of the following products:
Thumbnail for DDW 2024 - Full Program On Demand
Full DDW 2024 On Demand Program available now!

SOCIETY: AGA/AASLD

Moderators

Speaker Image for Heather Francis
Indiana University
Speaker Image for Andres Duarte-Rojo
University of Arkansas for Medical Sciences

Related Products

Thumbnail for Human and Experimental Cholestasis
Human and Experimental Cholestasis
METABOLIC OUTCOMES AND KEY EFFICACY DATA FROM A PHASE 2 TRIAL EVALUATING COMBINATION OBETICHOLIC ACID AND BEZAFIBRATE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS
Thumbnail for AASLD Presidential Plenary
AASLD Presidential Plenary
ASSOCIATION OF GLUCAGON-LIKE PEPTIDE-1 AGONISTS WITH CIRRHOSIS AND HEPATOCELLULAR CANCER IN METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
Thumbnail for Clinical Advances in Steatotis Liver Disease and MASH
Clinical Advances in Steatotis Liver Disease and MASH
SOCIETY: AGA Newer and novel tools in understanding and management of patients with MASLD